| Primary |
| Hiv Infection |
66.0% |
| Prophylaxis |
6.1% |
| Antifungal Prophylaxis |
5.0% |
| Depression |
3.4% |
| Diabetes Mellitus |
2.0% |
| Insomnia |
1.9% |
| Medical Diet |
1.9% |
| Diarrhoea |
1.8% |
| Hypertension |
1.8% |
| Drug Use For Unknown Indication |
1.2% |
| Neuropathy Peripheral |
1.2% |
| Headache |
1.0% |
| Hypertriglyceridaemia |
0.9% |
| Opportunistic Infection Prophylaxis |
0.9% |
| Pneumocystis Jiroveci Pneumonia |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Prurigo |
0.9% |
| Candidiasis |
0.8% |
| Myocardial Infarction |
0.7% |
| Abdominal Pain Upper |
0.7% |
|
| Pancreatitis |
15.9% |
| Hepatitis |
9.1% |
| Osteonecrosis |
9.1% |
| Renal Failure |
6.8% |
| Hepatic Enzyme Increased |
6.3% |
| Coronary Artery Disease |
5.1% |
| B-cell Lymphoma |
4.5% |
| Transaminases Increased |
4.5% |
| Varices Oesophageal |
4.5% |
| Death |
4.0% |
| Renal Failure Acute |
4.0% |
| Upper Gastrointestinal Haemorrhage |
4.0% |
| Blood Amylase Increased |
2.8% |
| Gastritis Erosive |
2.8% |
| Gastroenteritis |
2.8% |
| Herpes Simplex |
2.8% |
| Immune Reconstitution Syndrome |
2.8% |
| Pyrexia |
2.8% |
| Thrombocytopenia |
2.8% |
| Diabetes Mellitus Inadequate Control |
2.3% |
|
| Secondary |
| Hiv Infection |
63.2% |
| Prophylaxis |
4.9% |
| Antifungal Prophylaxis |
4.5% |
| Depression |
2.9% |
| Hypertension |
2.8% |
| Diabetes Mellitus |
2.5% |
| Medical Diet |
2.2% |
| Pyrexia |
2.0% |
| Asthma |
1.7% |
| Diarrhoea |
1.7% |
| Insomnia |
1.6% |
| Pneumocystis Jiroveci Pneumonia |
1.6% |
| Neuropathy Peripheral |
1.4% |
| Intervertebral Disc Protrusion |
1.3% |
| Anaemia |
1.1% |
| Anxiety |
0.9% |
| Drug Use For Unknown Indication |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Drug Exposure During Pregnancy |
0.9% |
| Hypercholesterolaemia |
0.9% |
|
| Pancreatitis |
13.8% |
| Osteonecrosis |
13.4% |
| Renal Failure |
8.7% |
| Pyrexia |
6.7% |
| Hepatitis |
6.3% |
| Mesenteric Vein Thrombosis |
4.7% |
| Hepatic Enzyme Increased |
4.3% |
| Immune Reconstitution Syndrome |
4.3% |
| Thrombotic Thrombocytopenic Purpura |
4.3% |
| Coronary Artery Disease |
3.6% |
| Transaminases Increased |
3.6% |
| B-cell Lymphoma |
3.2% |
| Blood Creatinine Increased |
3.2% |
| Renal Failure Acute |
3.2% |
| Varices Oesophageal |
3.2% |
| Gastritis Erosive |
2.8% |
| Thrombocytopenia |
2.8% |
| Upper Gastrointestinal Haemorrhage |
2.8% |
| Vomiting |
2.8% |
| Anal Cancer |
2.4% |
|
| Concomitant |
| Hiv Infection |
56.3% |
| Drug Use For Unknown Indication |
12.8% |
| Medical Diet |
3.3% |
| Diarrhoea |
3.3% |
| Antibiotic Prophylaxis |
2.6% |
| Hypertension |
2.2% |
| Diabetes Mellitus |
2.0% |
| Prophylaxis |
1.9% |
| Arthritis |
1.8% |
| Antifungal Prophylaxis |
1.6% |
| Hyperlipidaemia |
1.6% |
| Neuropathy Peripheral |
1.4% |
| Candidiasis |
1.2% |
| Infection Prophylaxis |
1.2% |
| Lung Disorder |
1.2% |
| Depression |
1.2% |
| Insomnia |
1.2% |
| Mineral Supplementation |
1.1% |
| Asthma Prophylaxis |
1.1% |
| Vitamin Supplementation |
1.1% |
|
| Pyrexia |
10.4% |
| Myocardial Infarction |
9.1% |
| Osteonecrosis |
7.3% |
| Renal Failure |
6.7% |
| Sepsis |
6.7% |
| Vomiting |
6.7% |
| Weight Decreased |
6.7% |
| Death |
5.5% |
| Thrombocytopenia |
5.5% |
| Hepatitis |
3.7% |
| Pneumonia Bacterial |
3.7% |
| Subcutaneous Emphysema |
3.7% |
| Acute Psychosis |
3.0% |
| Haemorrhagic Stroke |
3.0% |
| Immune Reconstitution Syndrome |
3.0% |
| Lung Disorder |
3.0% |
| Osteoporosis |
3.0% |
| Prothrombin Time Prolonged |
3.0% |
| Thrombotic Thrombocytopenic Purpura |
3.0% |
| Upper Gastrointestinal Haemorrhage |
3.0% |
|
| Interacting |
| Hiv Infection |
35.7% |
| Antifungal Prophylaxis |
14.3% |
| Depression |
14.3% |
| Drug Use For Unknown Indication |
14.3% |
| Diarrhoea |
7.1% |
| Gastritis Prophylaxis |
7.1% |
| Opportunistic Infection Prophylaxis |
7.1% |
|
| Vasoconstriction |
66.7% |
| Renal Failure |
33.3% |
|
